CSIMarket Company Name, Ticker, Customers, else..
 

Luminex Corporation  (NASDAQ: LMNX)

Luminex's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

LMNX Sales vs. its Competitors Q1 2021


Comparing the current results to its competitors, Luminex reported Revenue increase in the 1 quarter 2021 by 22.41 % year on year.
The revenue growth was below Luminex's competitors' average revenue growth of 94.19 %, achieved in the same quarter.

• List of LMNX Competitors

With a net margin of 18.02 % Luminex reported lower profitability than its competitors.

• More on LMNX Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Luminex Corporation Net Income in the 1 quarter 2021 grew year on year by 1100%, while most of its competitors have experienced a contraction in net income by -54.23 %.

<<  LMNX Stock Performance Comparisons





  

Overall company Market Share Q1 2021
Contrary to strong revenue growth of 22.41 % in Overall company, Luminex has lost market share within this division.




<<  More on LMNX Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Luminex Corporation




Co diagnostics Inc
Share Performance



-4.13%
Over The Past 5 Days
Co diagnostics Inc
Profile

Co Diagnostics Inc is a biotech company that follows a business-to-business (B2B) model. They develop and manufacture molecular diagnostics for various infectious diseases. Their revenue is generated by selling these diagnostics directly to healthcare organizations, laboratories, and research institutions.

More about Co diagnostics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5.000 mill. $ 0.721 mill. $ -47.056 mill.


Maravai Lifesciences Holdings Inc
Share Performance



+115.29%
This Year
Maravai Lifesciences Holdings Inc
Profile

Maravai Lifesciences Holdings Inc's business model revolves around providing integrated solutions for the development and manufacturing of biopharmaceutical products.

More about Maravai Lifesciences Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,083.331 mill. $ 207.886 mill. $ -136.080 mill.


Quantum si Incorporated
Share Performance



-29.07%
One Year
Quantum si Incorporated
Profile

Quantum si Incorporated's business model involves utilizing quantum technology to develop and provide innovative solutions for various industries.

More about Quantum si Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 166.836 mill. $ 1.322 mill. $ -98.519 mill.


Quanterix Corporation
Share Performance



-23.80%
This Quarter
Quanterix Corporation
Profile

Quanterix Corp's business model is centered around developing and commercializing ultra-sensitive digital immunoassay platforms, which enable the detection and measurement of biomarkers with exceptional precision and accuracy.

More about Quanterix Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 126.879 mill. $ 152.716 mill. $ -123.108 mill.


T2 Biosystems Inc
Share Performance



-28.57%
30 Days
T2 Biosystems Inc
Profile

T2 Biosystems Inc operates on a business model centered around developing and commercializing innovative diagnostic solutions for medical purposes. Their technology relies on magnetic resonance for the detection of pathogens, toxins, and other molecules associated with various diseases. By offering rapid, accurate, and portable diagnostic capabilities, T2 Biosystems aims to improve patient outcomes and facilitate appropriate treatment decisions in healthcare settings.

More about T2 Biosystems Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.009 mill. $ 7.677 mill. $ -42.954 mill.

Sources: Luminex Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Luminex Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.